| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 5.453 | 958 | 835 | 1.375 |
| Total Income - EUR | - | - | - | - | - | - | 5.453 | 958 | 835 | 1.375 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.152 | 2.561 | 1.065 | 686 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 3.301 | -1.603 | -230 | 689 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 3.138 | -1.632 | -233 | 557 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Urogin Healthcare S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 3.185 | 1.561 | 1.318 | 1.956 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 136 | 0 | 16 | 489 |
| Cash | - | - | - | - | - | - | 3.049 | 1.561 | 1.302 | 1.468 |
| Shareholders Funds | - | - | - | - | - | - | 3.178 | 1.556 | 1.318 | 1.868 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 7 | 5 | 0 | 89 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Urogin Healthcare S.r.l.